6,082 filings
Page 2 of 100
6-K
cqlh8j
20 Aug 24
B7-H3 Adc Us Fda Breakthrough Therapy Designation
6:30am
6-K
v1zh3
16 Aug 24
Statement: Zantac (Ranitidine) Litigation
6:22am
6-K
ic1e91
12 Aug 24
Director/pdmr Shareholding
11:04am
6-K
wc5h6acc7t3qs9lklz
6 Aug 24
Statement: Zantac (Ranitidine) Litigation
6:55am
6-K
ug6e67zv gyhai
2 Aug 24
Fda Expands Jemperli Approval
7:33am
6-K
1so 449ve4
1 Aug 24
Total Voting Rights
10:17am
6-K
tmnk3j1r49 yvsby
31 Jul 24
2ND Quarter Results
12:28pm
6-K
9q5b7xtu1s
29 Jul 24
Statement: Zantac (Ranitidine) Litigation
6:23am
6-K
nwahct26 9sxo
29 Jul 24
CHMP Positive Opinion on Arexvy for 50-59 at Risk
6:16am
6-K
qwmc8gpl9 h8g1yhbusd
19 Jul 24
Blenrep Ema Filing Acceptance
7:08am
6-K
830aj6098t ya
18 Jul 24
Director/pdmr Shareholding
11:53am
6-K
zybp tdup
16 Jul 24
Director/pdmr Shareholding
10:44am
6-K
3ivdovnclc xq
15 Jul 24
Director/pdmr Shareholding
1:14pm
6-K
yo0odf g6ve
12 Jul 24
Director/pdmr Shareholding
11:15am
6-K
617hlf3 l4c
3 Jul 24
GSK and Curevac Collaboration Restructured
6:27am
6-K
snijvn z957kec
1 Jul 24
Total Voting Rights
10:05am
6-K
3u13o9aeojprpihhc7lj
28 Jun 24
Statement: Zantac (Ranitidine) Litigation
1:15pm
6-K
znitqjgr8oog8ua34
24 Jun 24
Ema Validates Jemperli Marketing Authorisation
6:10am
6-K
897c d5pjkvx
24 Jun 24
Omjjara Approved In Japan for Myelofibrosis
6:05am
6-K
hzm4xfce91edpx3eijsu
21 Jun 24
Director/pdmr Shareholding
11:08am